-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Harbin Sanlian entered the administrative examination and approval stage with the imitation of 4 types of flurbiprofen gel plaster, which is expected to break the domestic monopoly
.
According to data from Meinenet, the total sales of this product in China's public medical institutions and physical pharmacies in cities in China will exceed 1.
7 billion yuan in 2020, a year-on-year increase of nearly 30%
.
.
According to data from Meinenet, the total sales of this product in China's public medical institutions and physical pharmacies in cities in China will exceed 1.
7 billion yuan in 2020, a year-on-year increase of nearly 30%
.
Source: official website of the State Food and Drug Administration
Flurbiprofen is a non-steroidal anti-inflammatory and analgesic.
It acts by inhibiting cyclooxygenase (COX) in the spinal cord and periphery to reduce the synthesis of prostaglandins.
It is suitable for rheumatoid arthritis, osteoarthritis, and ankylosing spine Inflammation, trauma pain, postoperative pain and other pain
.
It acts by inhibiting cyclooxygenase (COX) in the spinal cord and periphery to reduce the synthesis of prostaglandins.
It is suitable for rheumatoid arthritis, osteoarthritis, and ankylosing spine Inflammation, trauma pain, postoperative pain and other pain
.
At present, only flurbiprofen gel plaster of Japan's Mikasa Pharmaceutical (Beijing Tide Pharmaceutical is a packaging company ) is on sale in China.
According to data from Meinenet, the product will be used in urban public hospitals , county-level public hospitals, and urban communities in China in 2020 .
The total sales of the centers and township health centers (Chinese public medical institutions) and Chinese urban physical pharmacies exceeded 1.
7 billion yuan, a year-on-year increase of nearly 30%
.
According to data from Meinenet, the product will be used in urban public hospitals , county-level public hospitals, and urban communities in China in 2020 .
The total sales of the centers and township health centers (Chinese public medical institutions) and Chinese urban physical pharmacies exceeded 1.
7 billion yuan, a year-on-year increase of nearly 30%
.
Sales of terminal medicinal plasters in physical pharmacies in cities in China (unit: ten thousand yuan)
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
In recent years, the market scale of terminal medicinal plasters in Chinese urban physical pharmacies has steadily expanded.
It is expected to exceed 800 million yuan in 2021, a year-on-year increase of 10.
09%
.
It is expected to exceed 800 million yuan in 2021, a year-on-year increase of 10.
09%
.
2021E TOP5 products of terminal medicinal plasters in physical pharmacies in Chinese cities
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
In 2021E, the total market share of TOP5 products of terminalized medicinal plasters in Chinese urban physical pharmacies exceeds 70%.
Benzalkonium chloride plaster has been ranked first for many years, but the market share is declining year by year; flurbiprofen gel plaster has been sold in recent years The amount and ranking have risen steadily.
In 2018, it ranked TOP2 for the first time, and has been in this ranking since then, and its market share has increased year by year
.
Benzalkonium chloride plaster has been ranked first for many years, but the market share is declining year by year; flurbiprofen gel plaster has been sold in recent years The amount and ranking have risen steadily.
In 2018, it ranked TOP2 for the first time, and has been in this ranking since then, and its market share has increased year by year
.
Source: Meinenet database, official website of the State Drug Administration, etc.
Recently, Harbin Sanlian entered the administrative examination and approval stage with the imitation of 4 types of flurbiprofen gel plaster, which is expected to break the domestic monopoly
.
According to data from Meinenet, the total sales of this product in China's public medical institutions and physical pharmacies in cities in China will exceed 1.
7 billion yuan in 2020, a year-on-year increase of nearly 30%
.
.
According to data from Meinenet, the total sales of this product in China's public medical institutions and physical pharmacies in cities in China will exceed 1.
7 billion yuan in 2020, a year-on-year increase of nearly 30%
.
Source: official website of the State Food and Drug Administration
Flurbiprofen is a non-steroidal anti-inflammatory and analgesic.
It acts by inhibiting cyclooxygenase (COX) in the spinal cord and periphery to reduce the synthesis of prostaglandins.
It is suitable for rheumatoid arthritis, osteoarthritis, and ankylosing spine Inflammation, trauma pain, postoperative pain and other pain
.
It acts by inhibiting cyclooxygenase (COX) in the spinal cord and periphery to reduce the synthesis of prostaglandins.
It is suitable for rheumatoid arthritis, osteoarthritis, and ankylosing spine Inflammation, trauma pain, postoperative pain and other pain
.
At present, only flurbiprofen gel plaster of Japan's Mikasa Pharmaceutical (Beijing Tide Pharmaceutical is a packaging company ) is on sale in China.
According to data from Meinenet, the product will be used in urban public hospitals , county-level public hospitals, and urban communities in China in 2020 .
The total sales of the centers and township health centers (Chinese public medical institutions) and Chinese urban physical pharmacies exceeded 1.
7 billion yuan, a year-on-year increase of nearly 30%
.
According to data from Meinenet, the product will be used in urban public hospitals , county-level public hospitals, and urban communities in China in 2020 .
The total sales of the centers and township health centers (Chinese public medical institutions) and Chinese urban physical pharmacies exceeded 1.
7 billion yuan, a year-on-year increase of nearly 30%
.
Sales of terminal medicinal plasters in physical pharmacies in cities in China (unit: ten thousand yuan)
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
In recent years, the market scale of terminal medicinal plasters in Chinese urban physical pharmacies has steadily expanded.
It is expected to exceed 800 million yuan in 2021, a year-on-year increase of 10.
09%
.
It is expected to exceed 800 million yuan in 2021, a year-on-year increase of 10.
09%
.
2021E TOP5 products of terminal medicinal plasters in physical pharmacies in Chinese cities
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
In 2021E, the total market share of TOP5 products of terminalized medicinal plasters in Chinese urban physical pharmacies exceeds 70%.
Benzalkonium chloride plaster has been ranked first for many years, but the market share is declining year by year; flurbiprofen gel plaster has been sold in recent years The amount and ranking have risen steadily.
In 2018, it ranked TOP2 for the first time, and has been in this ranking since then, and its market share has increased year by year
.
Benzalkonium chloride plaster has been ranked first for many years, but the market share is declining year by year; flurbiprofen gel plaster has been sold in recent years The amount and ranking have risen steadily.
In 2018, it ranked TOP2 for the first time, and has been in this ranking since then, and its market share has increased year by year
.
Source: Meinenet database, official website of the State Drug Administration, etc.
Recently, Harbin Sanlian entered the administrative examination and approval stage with the imitation of 4 types of flurbiprofen gel plaster, which is expected to break the domestic monopoly
.
According to data from Meinenet, the total sales of this product in China's public medical institutions and physical pharmacies in cities in China will exceed 1.
7 billion yuan in 2020, a year-on-year increase of nearly 30%
.
.
According to data from Meinenet, the total sales of this product in China's public medical institutions and physical pharmacies in cities in China will exceed 1.
7 billion yuan in 2020, a year-on-year increase of nearly 30%
.
Source: official website of the State Food and Drug Administration
Flurbiprofen is a non-steroidal anti-inflammatory and analgesic.
It acts by inhibiting cyclooxygenase (COX) in the spinal cord and periphery to reduce the synthesis of prostaglandins.
It is suitable for rheumatoid arthritis, osteoarthritis, and ankylosing spine Inflammation, trauma pain, postoperative pain and other pain
.
It acts by inhibiting cyclooxygenase (COX) in the spinal cord and periphery to reduce the synthesis of prostaglandins.
It is suitable for rheumatoid arthritis, osteoarthritis, and ankylosing spine Inflammation, trauma pain, postoperative pain and other pain
.
At present, only flurbiprofen gel plaster of Japan's Mikasa Pharmaceutical (Beijing Tide Pharmaceutical is a packaging company ) is on sale in China.
According to data from Meinenet, the product will be used in urban public hospitals , county-level public hospitals, and urban communities in China in 2020 .
The total sales of the centers and township health centers (Chinese public medical institutions) and Chinese urban physical pharmacies exceeded 1.
7 billion yuan, a year-on-year increase of nearly 30%
.
Enterprise enterprise enterprise hospital hospital hospital pharmacy pharmacy pharmacyAccording to data from Meinenet, the product will be used in urban public hospitals , county-level public hospitals, and urban communities in China in 2020 .
The total sales of the centers and township health centers (Chinese public medical institutions) and Chinese urban physical pharmacies exceeded 1.
7 billion yuan, a year-on-year increase of nearly 30%
.
Sales of terminal medicinal plasters in physical pharmacies in cities in China (unit: ten thousand yuan)
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
In recent years, the market scale of terminal medicinal plasters in Chinese urban physical pharmacies has steadily expanded.
It is expected to exceed 800 million yuan in 2021, a year-on-year increase of 10.
09%
.
It is expected to exceed 800 million yuan in 2021, a year-on-year increase of 10.
09%
.
2021E TOP5 products of terminal medicinal plasters in physical pharmacies in Chinese cities
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
In 2021E, the total market share of TOP5 products of terminalized medicinal plasters in Chinese urban physical pharmacies exceeds 70%.
Benzalkonium chloride plaster has been ranked first for many years, but the market share is declining year by year; flurbiprofen gel plaster has been sold in recent years The amount and ranking have risen steadily.
In 2018, it ranked TOP2 for the first time, and has been in this ranking since then, and its market share has increased year by year
.
Benzalkonium chloride plaster has been ranked first for many years, but the market share is declining year by year; flurbiprofen gel plaster has been sold in recent years The amount and ranking have risen steadily.
In 2018, it ranked TOP2 for the first time, and has been in this ranking since then, and its market share has increased year by year
.
Source: Meinenet database, official website of the State Drug Administration, etc.